Picture of LumiraDx logo

LMDXF — LumiraDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

LumiraDx Ltd reports results for the quarter ended in March - Earnings Summary

* LumiraDx Ltd  LMDX.OQ  reported a quarterly adjusted loss
of 14
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue fell 82.5% to $22.17 million from a year ago;
analysts
expected $19.56 million. 
    * LumiraDx Ltd's reported EPS for the quarter was a loss
of 14
cents​.
    * The mean earnings estimate of analysts had risen by
about 16.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * LumiraDx Ltd shares had risen by 15.1% this quarter and
lost 40.6% so far this year.
    * The company reported a quarterly loss of $44.12 million.
    * Wall Street's median 12-month price target for LumiraDx
Ltd is
$1.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.14          -0.14          Met
 Dec. 31 2022      -0.20          -0.32          Missed
 Sep. 30 2022      -0.26          -0.47          Missed
 Jun. 30 2022      -0.26          -0.58          Missed

Recent news on LumiraDx

See all news